Trial intelligence / Profile preview

ATIS: Metamizole for Fever in Acute Ischemic Stroke

NCT02184260Phase 4Terminated

Sponsor
Boehringer Ingelheim
Start
Dec 1998
Primary completion
May 2002
01

Overview

A Phase 4 trial of metamizole in ischemic stroke, sponsored by Boehringer Ingelheim. Started Dec 1998; status: terminated.

02

Drugs

metamizole
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02184260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02184260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call